Stay updated on Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial

Sign up to get notified when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page content remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:09:50.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH website transition updates and says both “Super Intelligence” and “Artificial Intelligence” may appear during the terminology change.
    Difference
    1%
    Check dated 2026-10-25T13:08:04.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the study record remains inaccessible on a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T13:19:02.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T13:27:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new Study Protocol and Statistical Analysis Plan link is added under Study Documents, along with IPD sharing information and related study metadata. The update also introduces associated keywords and MeSH terms (e.g., Pembrolizumab, Rituximab, Waldenström's Macroglobulinemia) to improve searchability and context.
    Difference
    59%
    Check dated 2026-09-27T18:15:52.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previously visible study record content. This indicates the study details are currently inaccessible rather than updated content.
    Difference
    19%
    Check dated 2026-09-20T19:32:28.000Z thumbnail image

Stay in the know with updates to Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.